3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
11
Prostatic Neoplasms
9
Breast Neoplasms
9
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Neuroblastoma
6
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Melanoma
6
Lymphoma
6
Glioblastoma
6
Ovarian Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioma
4
Osteosarcoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Kidney Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms, Male
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Medulloblastoma
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
No trials found.